IE33077L - Epoxypropylphosphonic acid derivatives - Google Patents

Epoxypropylphosphonic acid derivatives

Info

Publication number
IE33077L
IE33077L IE681254A IE125468A IE33077L IE 33077 L IE33077 L IE 33077L IE 681254 A IE681254 A IE 681254A IE 125468 A IE125468 A IE 125468A IE 33077 L IE33077 L IE 33077L
Authority
IE
Ireland
Prior art keywords
compounds
cis
salts
agents
oxygen
Prior art date
Application number
IE681254A
Other versions
IE33077B1 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IE33077L publication Critical patent/IE33077L/en
Publication of IE33077B1 publication Critical patent/IE33077B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505Phosphonic acids containing oxirane groups; esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6587Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having two phosphorus atoms as ring hetero atoms in the same ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,236,956. (cis 1,2 - Epoxypropyl) - phosphonic acid derivatives. MERCK & CO. Inc. 24 Oct., 1968 [15 May, 1968], No. 50634/68. Heading C2C. The invention comprises a mixture of the (+) and (-) enantiomers of (cis 1,2-epoxypropyl)-phosphonic acid compounds of the formula in which X is O or S, Y is -OR, -SR, -NR 1 R 2 or halogen and Z is -OR, -SR, -NR 1 R 2 or halogen, with the proviso that at least one of Y and Z is other than -OR when X is oxygen, R is H or a substituted or unsubstituted hydrocarbyl or heterocyclic radical and each of R 1 and R 2 is H, a substituted or unsubstituted hydrocarbyl or heterocyclic radical or an acyl radical or NR 1 R 2 represents a heterocyclic amino group, also the cyclic derivatives of such compounds in which Y and Z are joined together by a divalent radical, e.g. polymethylene or arylene, and salts of such compounds in which at least one of Y and Z is -OH or -SH. The invention also comprises ( ) cis compounds of the formula or or in which X and Z are as defined above, A is -O-, -S- or -NR-, R 1 and R 2 when present in Z being a substituted or unsubstituted hydrocarbon or heterocyclic radical or an acyl radical, R 3 is H, an alkali or alkaline earth metal or C 1 -C 6 alkyl, with the proviso that at least one of X, Z and A is other than oxygen or an oxygen-containing radical. The compounds (I) may be obtained by the epoxidation of a compound of the formula with an oxidizing agent and compounds of Formul (II), (III) and (IV) may be prepared by treating a compound of the formula or or with an oxidizing agent. Several suitable oxidizing agents are specified, the preferred agents being peroxy compounds such as H 2 O 2 , an inorganic or organic per acid (including optically active organic per acids), an organic hydroperoxide or peroxyimidic acid which may be formed in situ from H 2 O 2 and a nitrile. The compounds may also be obtained by reacting the corresponding cis-propenyl phosphonous acid derivatives with an oxidizing agent as above so as to convert the phosphorus atom from P<SP>III</SP> to P<SP>v</SP> and to epoxidize the olefinic double bond in the one reaction. The products when they are other than salts may be converted to salts, e.g. the Na, Ca, Mg, piperazine, ethylenediamine, benzylamine or phenethylamine salts. The cis-propenyl phosphonic compounds used as starting materials may be obtained from the cis-propenyl phosphonic (or thiophosphonic)-dichloride by reacting with an alcohol, thiol or amine, the reaction being carried out with more than one such reactant and in more than one stage as appropriate and when X in the products is sulphur the latter may be replaced by oxygen by treatment with peroxy-trifluoroacetic acid or with bromine water. The ( )(cis - 1,2 - epoxypropyl)-phosphonic acid and its salts and labile esters have antibacterial properties and may be administered orally, e.g. as capsules or tablets or in an orally administratable liquid solution or suspension. The formulations may be prepared from diluents, granulating agents, preservatives, binders, flavouring agents and coating agents. The agents may also be administered parenterally by injection in a sterile vehicle. 1,236,956. Œ(cis 1,2 - Epoxypropyl) - phosphonic acid derivatives. MERCK & CO. Inc. 24 Oct., 1968 [15 May, 1968], No. 50634/68. Heading C2C. The invention comprises a mixture of the (+) and (-) enantiomers of (cis 1,2-epoxypropyl)-phosphonic acid compounds of the formula in which X is O or S, Y is -OR, -SR, -NR 1 R 2 or halogen and Z is -OR, -SR, -NR 1 R 2 or halogen, with the proviso that at least one of Y and Z is other than -OR when X is oxygen, R is H or a substituted or unsubstituted hydrocarbyl or heterocyclic radical and each of R 1 and R 2 is H, a substituted or unsubstituted hydrocarbyl or heterocyclic radical or an acyl radical or NR 1 R 2 represents a heterocyclic amino group, also the cyclic derivatives of such compounds in which Y and Z are joined together by a divalent radical, e.g. polymethylene or arylene, and salts of such compounds in which at least one of Y and Z is -OH or -SH. The invention also comprises (Œ) cis compounds of the formula or or in which X and Z are as defined above, A is -O-, -S- or -NR-, R 1 and R 2 when present in Z being a substituted or unsubstituted hydrocarbon or heterocyclic radical or an acyl radical, R 3 is H, an alkali or alkaline earth metal or C 1 -C 6 alkyl, with the proviso that at least one of X, Z and A is other than oxygen or an oxygen-containing radical. The compounds (I) may be obtained by the epoxidation of a compound of the formula with an oxidizing agent and compounds of Formulµ (II), (III) and (IV) may be prepared by treating a compound of the formula or or with an oxidizing agent. Several suitable oxidizing agents are specified, the preferred agents being peroxy compounds such as H 2 O 2 , an inorganic or organic per acid (including optically active organic per acids), an organic hydroperoxide or peroxyimidic acid which may be formed in situ from H 2 O 2 and a nitrile. The compounds may also be obtained by reacting the corresponding cis-propenyl phosphonous acid derivatives with an oxidizing agent as above so as to convert the phosphorus atom from P<SP>III</SP> to P<SP>v</SP> and to epoxidize the olefinic double bond in the one reaction. The products when they are other than salts may be converted to salts, e.g. the Na, Ca, Mg, piperazine, ethylenediamine, benzylamine or phenethylamine salts. The cis-propenyl phosphonic compounds used as starting materials may be obtained from the cis-propenyl phosphonic (or thiophosphonic)-dichloride by reacting with an alcohol, thiol or amine, the reaction being carried out with more than one such reactant and in more than one stage as appropriate and when X in the products is sulphur the latter may be replaced by oxygen by treatment with peroxy-trifluoroacetic acid or with bromine water. The (Œ)(cis - 1,2 - epoxypropyl)-phosphonic acid and its salts and labile esters have antibacterial properties and may be administered orally, e.g. as capsules or tablets or in an orally administratable liquid solution or suspension. The formulations may be prepared from diluents, granulating agents, preservatives, binders, flavouring agents and coating agents. The agents may also be administered parenterally by injection in a sterile vehicle. [GB1236956A]
IE1254/68A 1968-05-15 1968-10-21 Epoxypropylphoshonic and thiophosphonic acid derivatives IE33077B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72942968A 1968-05-15 1968-05-15

Publications (2)

Publication Number Publication Date
IE33077L true IE33077L (en) 1969-11-15
IE33077B1 IE33077B1 (en) 1974-03-20

Family

ID=24930977

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1254/68A IE33077B1 (en) 1968-05-15 1968-10-21 Epoxypropylphoshonic and thiophosphonic acid derivatives

Country Status (17)

Country Link
AT (1) AT299245B (en)
BE (1) BE723079A (en)
BR (1) BR6803537D0 (en)
CH (1) CH515937A (en)
DE (1) DE1805675A1 (en)
ES (1) ES359535A1 (en)
FR (1) FR2008618A1 (en)
GB (1) GB1236956A (en)
HU (1) HU162829B (en)
IE (1) IE33077B1 (en)
IL (1) IL30915A0 (en)
LU (1) LU57187A1 (en)
MT (1) MTP584B (en)
NL (1) NL6814981A (en)
PL (1) PL71417B1 (en)
SE (1) SE367205B (en)
ZM (1) ZM14068A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117964661B (en) * 2024-04-01 2024-06-07 深圳创元生物医药科技有限公司 Preparation method of fosfomycin genotoxic impurity C

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2770610A (en) * 1952-10-30 1956-11-13 Monsanto Chemicals Esters of epoxidized phosphonic acids and halogenated organic materials stabilized therewith

Also Published As

Publication number Publication date
LU57187A1 (en) 1969-05-16
IL30915A0 (en) 1968-12-26
MTP584B (en) 1970-01-21
IE33077B1 (en) 1974-03-20
SE367205B (en) 1974-05-20
FR2008618A1 (en) 1970-01-23
GB1236956A (en) 1971-06-23
NL6814981A (en) 1969-11-18
CH515937A (en) 1971-11-30
DE1805675A1 (en) 1969-12-11
BR6803537D0 (en) 1973-02-22
PL71417B1 (en) 1974-06-29
AT299245B (en) 1972-06-12
ES359535A1 (en) 1970-08-16
BE723079A (en) 1969-04-29
ZM14068A1 (en) 1970-06-18
HU162829B (en) 1973-04-28

Similar Documents

Publication Publication Date Title
HU9300759D0 (en) Method for producing triazolo-pyridine derivatives and pharmaceutical preparatives containing said compounds as active substance
GB1440847A (en) Carboxyethyl ester of n-phosphonomethyl glycine salts thereof and their use as herbicides
HUT48307A (en) Process for production of herbicides containing as active substance cyclic internal anhydrid either its free acid form or its salts and process for the production of the activ substances
GB1379790A (en) Process for producing 7-acylamido-3-cephem-4-carboxylic acids
SE8705150D0 (en) NOVEL ANTIARRHYTHMIC AGENTS
IE33077B1 (en) Epoxypropylphoshonic and thiophosphonic acid derivatives
GB1196229A (en) Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
NO873784L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE NAPHALAND AND INDANDER DERIVATIVES.
DE3770680D1 (en) SPERGUALIN-LIKE CONNECTIONS AND THEIR PRODUCTION PROCESS.
US3625982A (en) (1,2-epoxypropyl)phosphonous acid derivatives
US3658840A (en) Thiophosphorus acid-n-vinyl phthalimide adducts
DE3777325D1 (en) 2-AMINO-4-PHOSPHONYL BUTTER ACID DERIVATIVES AND PRODUCTION OF 2-AMINO-4-PHOSPHINYL BUTTER ACIDS.
IL86846A (en) Pharmaceutical compositions for preventing and treating heart failure containing indane or naphthalene carboxylic acids
US3897488A (en) Chlorobenzene-2,4-disulphonic acid amide carboxylic acids
GB1363916A (en) Process for the preparation of percarboxylic acids
GB1426541A (en) Cephalosporanic derivatives process for their preparation and compositions incorporating them
US2654743A (en) Delta-piperidinobutyl diphenylacetate salt of penicillin
US4883890A (en) Unsymmetrical organic disulfide compounds useful as antiradiation agents
SU743580A3 (en) Method of producing bis-(2-aminocyclopentene-1-yl-1 thyocarbonyl) disulfides
DE976155C (en) Process for the preparation of phenthiazine derivatives and their salts
IL30918A (en) Process for the preparation of cis-1,2-epoxypropyl-phosphonic acid derivatives
US3864495A (en) Sulphonamides compositions and method for treating edema
GB191120242A (en) Manufacture of a Stable Preparation from Hydrogen Peroxide and Urea.
EP0357792A4 (en) Process for preparing pyridine-2,3-dicarboxylic acid compounds
IE37905L (en) 7-acylamino-3-methyl-3-cephem-4-carboxylic acids